Please login to the form below

Not currently logged in
Email:
Password:

GlycoVaxyn

This page shows the latest GlycoVaxyn news and features for those working in and with pharma, biotech and healthcare.

GSK buys vaccine specialist GlycoVaxyn for $190m

GSK buys vaccine specialist GlycoVaxyn for $190m

GSK buys vaccine specialist GlycoVaxyn for $190m. Acquisition will expand GSK’ s early vaccines pipeline. ... GlaxoSmithKline (GSK) has taken control of Swiss company GlycoVaxyn in a $190m deal that bolsters its early vaccines pipeline.

Latest news

  • Janssen boosts vaccines pipeline with GlycoVaxyn deal

    Janssen boosts vaccines pipeline with GlycoVaxyn deal. Research will focus on targeting multiple bacterial pathogens. ... Janssen has agreed a deal with Swiss vaccines specialist GlycoVaxyn to research and develop a vaccine for multiple bacterial

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • GlycoVaxyn appoints Gerd Zettlmeissl as chairman GlycoVaxyn appoints Gerd Zettlmeissl as chairman

    GlycoVaxyn appoints Gerd Zettlmeissl as chairman. He will join the Swiss vaccines company in June. ... Swiss vaccines company GlycoVaxyn has appointed Gerd Zettlmeissl as chairman of the board of directors with effect from June, when he will take over

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...
The Holy Grail of HCP Access
This is the data you need to gain access....

Infographics